The lack of NRXN3 can affect synaptic development, synaptic signaling, and neurotransmitter release, and the downregulation of nrxn3 expression has been identified as the highest-risk gene associated with Alzheimer disease (AD) and senescence (Zheng et al., 2018). The gene discussed is NRXN3; the disease is Alzheimer disease.